251 related articles for article (PubMed ID: 16939734)
1. Revisiting steroids in the primary treatment of acute Kawasaki disease.
Burns JC
J Pediatr; 2006 Sep; 149(3):291-2. PubMed ID: 16939734
[No Abstract] [Full Text] [Related]
2. Treatment of Kawasaki disease.
Taddio A; Rosé CD
N Engl J Med; 2007 Jun; 356(26):2747; author reply 2748. PubMed ID: 17600908
[No Abstract] [Full Text] [Related]
3. Adverse effects of methylprednisolone pulse therapy in refractory Kawasaki disease.
Miura M; Ohki H; Yoshiba S; Ueda H; Sugaya A; Satoh M; Yamagishi H
Arch Dis Child; 2005 Oct; 90(10):1096-7. PubMed ID: 16177169
[No Abstract] [Full Text] [Related]
4. High-dose aspirin in Kawasaki disease.
Shulman ST
J Pediatr; 1999 Apr; 134(4):523-4. PubMed ID: 10190936
[No Abstract] [Full Text] [Related]
5. Treatment of Kawasaki disease with corticosteroid.
Shulman ST; Rowley AH
J Pediatr; 1996 Sep; 129(3):483; author reply 484-5. PubMed ID: 8804349
[No Abstract] [Full Text] [Related]
6. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
Hsieh KS; Weng KP; Lin CC; Huang TC; Lee CL; Huang SM
Pediatrics; 2004 Dec; 114(6):e689-93. PubMed ID: 15545617
[TBL] [Abstract][Full Text] [Related]
7. Arthritis in Kawasaki disease after responding to intravenous immunoglobulin treatment.
Lee KY; Oh JH; Han JW; Lee JS; Lee BC
Eur J Pediatr; 2005 Jul; 164(7):451-2. PubMed ID: 15782294
[No Abstract] [Full Text] [Related]
8. Clinical and epidemiological characteristics of children with Kawasaki disease in Turkey.
Ozdemir H; Ciftçi E; Tapisiz A; Ince E; Tutar E; Atalay S; Dogru U
J Trop Pediatr; 2010 Aug; 56(4):260-2. PubMed ID: 20007257
[TBL] [Abstract][Full Text] [Related]
9. Myocardial infarction associated with Kawasaki disease in adult man: case report and review of literature.
Serpytis P; Petrulioniene Z; Gargalskaite U; Gedminaite A; Panaviene V
Am J Med; 2015 Mar; 128(3):e1-3. PubMed ID: 25446304
[No Abstract] [Full Text] [Related]
10. [Reply to questions regarding diagnosis and treatment of Kawasaki disease].
Wang HW
Zhonghua Er Ke Za Zhi; 2006 May; 44(5):337-8. PubMed ID: 16780708
[No Abstract] [Full Text] [Related]
11. Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin.
Dale RC; Saleem MA; Daw S; Dillon MJ
J Pediatr; 2000 Nov; 137(5):723-6. PubMed ID: 11060542
[TBL] [Abstract][Full Text] [Related]
12. Primary treatment of incomplete Kawasaki disease with infliximab and methylprednisolone in a patient with a contraindication to intravenous immune globulin.
Shirley DA; Stephens I
Pediatr Infect Dis J; 2010 Oct; 29(10):978-9. PubMed ID: 20431427
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease.
Newburger JW; Sleeper LA; McCrindle BW; Minich LL; Gersony W; Vetter VL; Atz AM; Li JS; Takahashi M; Baker AL; Colan SD; Mitchell PD; Klein GL; Sundel RP;
N Engl J Med; 2007 Feb; 356(7):663-75. PubMed ID: 17301297
[TBL] [Abstract][Full Text] [Related]
14. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
Furukawa T; Kishiro M; Akimoto K; Nagata S; Shimizu T; Yamashiro Y
Arch Dis Child; 2008 Feb; 93(2):142-6. PubMed ID: 17962370
[TBL] [Abstract][Full Text] [Related]
15. An Uncommon Complication of a Common Disease: Pneumatosis Intestinalis in an Infant with Kawasaki Disease.
Ferstenfeld I; Shemer A; Razon Y; Yeshayahu Y
Isr Med Assoc J; 2019 Nov; 21(11):763-765. PubMed ID: 31713369
[No Abstract] [Full Text] [Related]
16. Is there a role for corticosteroids in Kawasaki disease?
Shulman ST
J Pediatr; 2003 Jun; 142(6):601-3. PubMed ID: 12838185
[No Abstract] [Full Text] [Related]
17. High-dose aspirin for Kawasaki disease: outdated myth or effective aid?
Amarilyo G; Koren Y; Brik Simon D; Bar-Meir M; Bahat H; Helou MH; Mendelson A; Hezkelo N; Chodick G; Berkun Y; Eisenstein E; Butbul Aviel Y; Barkai G; Bolkier Y; Padeh S; Brik R; Hashkes PJ; Harel L; Uziel Y
Clin Exp Rheumatol; 2017; 35 Suppl 103(1):209-212. PubMed ID: 28079513
[TBL] [Abstract][Full Text] [Related]
18. Corticosteroid pulse combination therapy for refractory Kawasaki disease: a randomized trial.
Ogata S; Ogihara Y; Honda T; Kon S; Akiyama K; Ishii M
Pediatrics; 2012 Jan; 129(1):e17-23. PubMed ID: 22144699
[TBL] [Abstract][Full Text] [Related]
19. Current recommendations for the pharmacologic therapy in Kawasaki syndrome and management of its cardiovascular complications.
De Rosa G; Pardeo M; Rigante D
Eur Rev Med Pharmacol Sci; 2007; 11(5):301-8. PubMed ID: 18074939
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporin rapidly diminished a severe lupus-associated macrophage association syndrome refractory to pulsed methylprednisolone and intravenous immunoglobulin.
Takizawa Y; Maruyama J; Setoguchi K
Scand J Rheumatol; 2009; 38(6):492-4. PubMed ID: 19922027
[No Abstract] [Full Text] [Related]
[Next] [New Search]
